Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07179276

Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock

Led by University Hospital, Clermont-Ferrand · Updated on 2026-04-29

750

Participants Needed

27

Research Sites

91 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Sepsis is a dysregulated host response to infection that leads to life-threatening organ dysfunction and represents a major healthcare problem. Septic shock is the most severe form, characterized by increased capillary permeability and vasodilation, resulting in hypotension and tissue hypoxia. Early identification and treatment of tissue hypoperfusion are pivotal components of initial resuscitation to limit progression to multiple organ dysfunction and death. The 2021 Surviving Sepsis Guidelines recommend guiding initial resuscitation by targeting decreases in serum lactate levels in patients with elevated lactate. However, although elevated lactate levels may reflect tissue hypoxia, serum lactate is not a direct marker of tissue perfusion. Hyperlactatemia may be attributable to mechanisms other than tissue hypoperfusion, such as accelerated aerobic glycolysis driven by excessive β-adrenergic stimulation or impaired clearance (e.g., in liver failure). The venous-to-arterial carbon dioxide partial pressure difference (CO₂ gap), which is inversely related to cardiac output, has been shown to reflect the adequacy of venous blood flow to remove CO₂ from tissues. The CO₂ gap is closely linked to microcirculatory blood flow during the early resuscitation phase of septic shock and may effectively identify persistent tissue hypoperfusion in shock states. A persistently high CO₂ gap during early resuscitation has been associated with significantly higher 28-day mortality and increased Sequential Organ Failure Assessment (SOFA) scores. Moreover, the CO₂ gap has been shown to respond to changes in cardiac output during inotrope infusion in patients with low blood flow, suggesting that its assessment could be useful for therapeutic adjustments. Therefore, there are compelling arguments to evaluate the usefulness of the CO₂ gap in guiding early resuscitation in patients with septic shock. The investigators postulated that CO₂ gap-guided early resuscitation may be more effective in improving outcomes than lactate-guided resuscitation.

CONDITIONS

Official Title

Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 years or older
  • Acutely admitted to a study intensive care unit (ICU)
  • Primary diagnosis of septic shock according to Sepsis-3 criteria
  • Suspected or documented infection or positive blood culture
  • Acute increase of at least 2 points in Sequential Organ Failure Assessment (SOFA) score due to infection
  • Serum lactate level greater than 2 mmol/l
  • Requirement of vasopressors (any dose of norepinephrine) to maintain mean arterial pressure of at least 65 mmHg despite adequate fluid resuscitation (minimum 1L intravenous fluid in last 24 hours prior to screening)
Not Eligible

You will not qualify if you...

  • Septic shock lasting more than 12 hours at screening
  • Hypotension caused by reasons other than sepsis (e.g., acute bleeding)
  • Decision not to resuscitate, limit care, or not intubate made before consent
  • Imminent or inevitable death or life expectancy less than 3 months due to underlying disease
  • Planned surgery within first 24 hours after randomization
  • Refusal to participate by patient or relatives
  • Participation in another randomized clinical trial that may affect the primary outcome
  • Previous enrollment in this CARBON trial
  • Known pregnancy
  • Legal protection status preventing consent (e.g., incompetence without guardian, incarceration)
  • No affiliation with the French health care system

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 27 locations

1

CHu Angers

Angers, France

Not Yet Recruiting

2

CH Aurillac

Aurillac, France

Not Yet Recruiting

3

CH de la Côte Basque

Bayonne, France

Actively Recruiting

4

CHU Bordeaux Hôpital Haut Lévèque

Bordeaux, France

Actively Recruiting

5

CHU Bordeaux Pellegrin Hospital

Bordeaux, France

Actively Recruiting

6

CHU Clermont-Ferrand Estaing

Clermont-Ferrand, France

Actively Recruiting

7

CHU Clermont-Ferrand Gabriel Montpied

Clermont-Ferrand, France

Actively Recruiting

8

CHU Dijon

Dijon, France

Actively Recruiting

9

CHU Grenoble

Grenoble, France

Not Yet Recruiting

10

CH Le puy en Velay

Le Puy-en-Velay, France

Actively Recruiting

11

HCL - Lyon Sud

Lyon, France

Not Yet Recruiting

12

HCL Hôpital Edouard Herriot

Lyon, France

Not Yet Recruiting

13

CHU Montpellier

Montpellier, France

Actively Recruiting

14

CH Moulins-Yzeure

Moulins, France

Not Yet Recruiting

15

CHU Nantes

Nantes, France

Actively Recruiting

16

CHU Nîmes

Nîmes, France

Not Yet Recruiting

17

APHP Beaujon

Paris, France

Actively Recruiting

18

APHP Bicêtre

Paris, France

Actively Recruiting

19

APHP La pitié Salpêtrière - Anesthésie et soin intensif

Paris, France

Actively Recruiting

20

APHP Lariboisière

Paris, France

Actively Recruiting

21

CHU la pitié slapêtrière - Anesthésie Réanimation

Paris, France

Actively Recruiting

22

CHU Poitiers

Poitiers, France

Actively Recruiting

23

CHU Rennes

Rennes, France

Actively Recruiting

24

CHRU Strasbourg - Service d'anesthésie-Réanimation médicale

Strasbourg, France

Actively Recruiting

25

CHU Strasbourg Service d'Anesthésie-Réanimation chirurgicale

Strasbourg, France

Actively Recruiting

26

Chu Toulouse

Toulouse, France

Actively Recruiting

27

CH Vichy

Vichy, France

Not Yet Recruiting

Loading map...

Research Team

L

Lise Laclautre

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here